Reporting of Drug Expenditures in the MCBS.
- Published in:
- Health Care Financing Review, 2003, v. 25, n. 2, p. 23
- By:
- Publication type:
- Article
Works matching IS 01958631 AND DT 2003 AND VI 25 AND IP 2
Results: 8
1
2
Medicare Drugs.
- Published in:
- Health Care Financing Review, 2003, v. 25, n. 2, p. 1
- Publication type:
- Article
3
Medicare Beneficiary's Use of Prescription Drug Discount Cards, CY 2002.
- Published in:
- Health Care Financing Review, 2003, v. 25, n. 2, p. 91
- By:
- Publication type:
- Article
4
Racial Disparities in Prescription Drug Use Among Dually Eligible Beneficiaries.
- Published in:
- Health Care Financing Review, 2003, v. 25, n. 2, p. 77
- By:
- Publication type:
- Article
5
Prescription Drug Benefits: Cost Management Issues for Medicare.
- Published in:
- Health Care Financing Review, 2003, v. 25, n. 2, p. 7
- By:
- Publication type:
- Article
6
Racial and Ethnic Disparities in Prescription Coverage and Medication Use.
- Published in:
- Health Care Financing Review, 2003, v. 25, n. 2, p. 63
- By:
- Publication type:
- Article
7
Participation and Crowd-Out in a Medicare Drug Benefit: Simulation Estimates.
- Published in:
- Health Care Financing Review, 2003, v. 25, n. 2, p. 47
- By:
- Publication type:
- Article
8
Predictability of Prescription Drug Expenditures for Medicare Beneficiaries.
- Published in:
- Health Care Financing Review, 2003, v. 25, n. 2, p. 37
- By:
- Publication type:
- Article